Study guide

3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways

Nutritionist-Dietitian Licensure Examination NDLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian

1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets

2 Chapter 2: Anatomy and Physiology for Nutrition I

2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite

3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism

3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways

4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry

4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance

5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI

5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines

6 Chapter 6: Diet Computation and Clinical Nutrition Assessment

6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment

7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data

7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment

8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders

8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight

9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease

9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract

10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions

10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders

11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition

11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults

12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition

12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications

13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling

13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories

14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition

14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs

15 Chapter 15: Community Nutrition and Population Assessment

15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)

16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance

16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System

17 Chapter 17: Nutrition Education and Program Evaluation

17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation

18 Chapter 18: Program Planning, Interventions, and Food Security

18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations

19 Chapter 19: Nutrition Governance, Networking, and Program History

19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems

20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws

20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions

21 Chapter 21: Nutrition in the Life Cycle I

21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs

22 Chapter 22: Nutrition in the Life Cycle II

22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs

23 Chapter 23: Food Science and Plant Foods

23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery

24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods

24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques

25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality

25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production

26 Chapter 26: Food Microbiology, Preservation, and Food Law

26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling

27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety

27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service

28 Chapter 28: Food Service Systems, Production Planning, and Menus

28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization

29 Chapter 29: Distribution, Purchasing, and Storage

29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation

30 Chapter 30: Cost Control, Financial Management, and Facility Layout

30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics

31 Chapter 31: Equipment, Management, and Human Resources

31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline

32 Chapter 32: Labor Law, Permits, and Food Service Marketing

32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service

3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways

Key Takeaways Explain This Topic AI

Amylose features linear α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) glycosidic bonds yielding a compact helical structure and slower enzymatic hydrolysis, whereas amylopectin contains branched α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) linkages every 24 to 30 glucose units that accelerate amylolytic breakdown.

Apical enterocyte monosaccharide uptake relies on secondary active transport via sodium-glucose cotransporter 1 (SGLT-1) for glucose and galactose, energized by the basolateral N a + / K + Na^+/K^+ N a + / K + ATPase, whereas fructose is absorbed independently via facilitated diffusion through GLUT-5.

Phosphofructokinase-1 (PFK-1) represents the committed, rate-limiting control point of glycolysis, allosterically activated by fructose-2,6-bisphosphate and AMP, while being allosterically inhibited by high cellular ATP and cytosolic citrate.

The pentose phosphate pathway generates cytosolic NADPH required for reductive lipid synthesis and the regeneration of reduced glutathione, alongside ribose-5-phosphate for nucleotide biosynthesis, with glucose-6-phosphate dehydrogenase (G6PD) deficiency predisposing erythrocytes to acute hemolytic crises under oxidative challenge.

Glycemic Load (GL) integrates carbohydrate quality (Glycemic Index) with quantitative serving portion size; foods exhibiting a high GI but minimal carbohydrate density produce small postprandial glucose surges, whereas carbohydrate-dense staples elicit high glycemic loads.

Last updated: October 2026

Carbohydrates represent the primary dietary source of metabolic energy for human physiological processes, supplying approximately 4 kcal/g (16.7 kJ/g) of metabolizable energy. In clinical dietetics and metabolic biochemistry, understanding the molecular configuration of carbohydrates, their luminal hydrolysis, transport kinetics across the intestinal mucosal barrier, and their intrahepatic and peripheral fates is essential for managing diabetes mellitus, critical illness, glycogen storage diseases, and metabolic syndrome.

Carbohydrate Classification and Chemistry

Carbohydrates are polyhydroxy aldehydes or ketones, or substances that yield these compounds upon hydrolysis. They are categorized based on their degree of polymerization into monosaccharides, disaccharides, oligosaccharides, and polysaccharides.

Monosaccharides

Monosaccharides are the simplest carbohydrate units and cannot be hydrolyzed into smaller carbon chains:

Hexoses ( C 6 H 12 O 6 C_6H_{12}O_6 C 6 ​ H 12 ​ O 6 ​ ): The principal dietary hexoses are D-glucose (an aldohexose), D-galactose (an aldohexose and C-4 epimer of glucose), and D-fructose (a ketohexose). In aqueous solutions, monosaccharides exist predominantly in cyclic hemiacetal or hemiketal ring forms: pyranose (six-membered ring) or furanose (five-membered ring).

Isomerism and Anomers: The cyclization creates an asymmetric center at the former carbonyl carbon, known as the anomeric carbon (C-1 in aldoses, C-2 in ketoses). Mutarotation establishes an equilibrium between α \alpha α (hydroxyl oriented downward in Haworth projection) and β \beta β (hydroxyl oriented upward) anomers.

Pentoses ( C 5 H 10 O 5 C_5H_{10}O_5 C 5 ​ H 10 ​ O 5 ​ ): Ribose and deoxyribose serve as structural backbones for ribonucleic acid (RNA), deoxyribonucleic acid (DNA), and high-energy nucleotides (ATP, NADH, FADH2, NADPH).

Disaccharides

Disaccharides consist of two hexose units joined by a condensation reaction yielding an O-glycosidic bond:

Maltose: Formed by two α \alpha α -D-glucopyranose units linked by an α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) glycosidic bond. It is an intermediate product of starch hydrolysis and retains a free anomeric carbon, functioning as a reducing sugar.

Lactose: The predominant carbohydrate in mammalian milk, composed of β \beta β -D-galactopyranose and α \alpha α -D-glucopyranose joined by a β ( 1 → 4 ) \beta(1\to4) β ( 1 → 4 ) glycosidic bond. It is a reducing sugar.

Sucrose: Table sugar, composed of α \alpha α -D-glucopyranose and β \beta β -D-fructofuranose linked via an α ( 1 → β 2 ) \alpha(1\to\beta2) α ( 1 → β 2 ) glycosidic bond. Because the bond links the anomeric carbons of both monosaccharides (C-1 of glucose and C-2 of fructose), sucrose has no free hemiacetal or hemiketal group and is a non-reducing sugar .

Trehalose: Composed of two α \alpha α -D-glucose units joined by an α ( 1 → 1 ) \alpha(1\to1) α ( 1 → 1 ) glycosidic linkage. Found in mushrooms and yeast, it is also a non-reducing sugar.

Polysaccharides: Starch and Glycogen

Polysaccharides are high-molecular-weight polymers composed of repeating monosaccharide subunits:

Amylose: A linear, unbranched polymer of D-glucose units linked exclusively by α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) glycosidic bonds. Amylose adopts a tight three-dimensional helical conformation that limits water access and slows down enzymatic hydrolysis by α \alpha α -amylase. Retrograded amylose forms type 2 and type 3 resistant starch.

Amylopectin: A branched polymer comprising a linear backbone of α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) glycosidic bonds with α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch points occurring every 24 to 30 glucose residues . Branching exposes numerous non-reducing ends to amylolytic cleavage, facilitating rapid enzymatic breakdown and eliciting a steeper postprandial glycemic surge than amylose.

Glycogen: The animal storage polysaccharide, concentrated in the liver (up to 5–6% of wet organ weight, ~100–120 g) and skeletal muscle (1–2% wet weight, ~400–500 g). Glycogen is structurally similar to amylopectin but far more densely branched, with α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch points occurring every 8 to 12 glucose units , ensuring rapid mobilization of glucose during exercise or hypoglycemia.

  • Carbohydrate Primary Linkage Monomer Composition Reducing Status Clinical / Physiological Significance
  • Maltose α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) Glucose + Glucose Reducing Intermediate starch breakdown product

Lactose β ( 1 → 4 ) \beta(1\to4) β ( 1 → 4 ) Galactose + Glucose Reducing Requires mucosal lactase; primary infant carbohydrate

Sucrose α ( 1 → β 2 ) \alpha(1\to\beta2) α ( 1 → β 2 ) Glucose + Fructose Non-reducing High osmolarity; metabolized rapidly by liver

Amylose α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) Glucose (linear) Reducing end Low GI starch fraction; forms resistant starch

Amylopectin α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) & α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) Glucose (branched) Reducing ends High GI starch fraction; hydrolyzed rapidly

Glycogen α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) & α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) Glucose (highly branched) Reducing end Endogenous glucose reserve; rapid mobilization

Dietary Fiber: Viscous Soluble vs. Insoluble Fractions

Dietary fiber consists of non-digestible carbohydrates and lignin that are intrinsic and intact in plants. Functional fiber consists of isolated, non-digestible carbohydrates that have proven beneficial physiological effects in humans. Total fiber is the sum of dietary fiber and functional fiber.

Soluble, Viscous, and Fermentable Fiber

Soluble fibers dissolve in water to form viscous gels within the gastrointestinal tract:

Major Types: Pectins (citrus fruits, apples), β \beta β -glucans (oats, barley), plant gums (guar gum, gum arabic), and mucilages (psyllium husk).

Physiological Mechanisms:

Delayed Gastric Emptying: High viscosity increases chyme transit time through the stomach and upper small intestine, blunting postprandial glucose spikes and prolonging satiety signals.

Interference with Micelle Diffusion: Viscous gels thicken the unstirred water layer along the brush border, impeding lipid and carbohydrate diffusion to mucosal transport sites.

Bile Acid Sequestration: Soluble fibers bind bile acids in the ileum, preventing their enterohepatic reabsorption and forcing the liver to convert endogenous cholesterol into bile salts, which upregulates hepatic LDL receptors and lowers serum LDL-C.

Colonic Fermentation: Anaerobic microflora ferment soluble fibers into short-chain fatty acids (SCFAs) : acetate (C2), propionate (C3), and butyrate (C4). Butyrate serves as the primary metabolic fuel for colonocytes; propionate travels to the liver via the portal vein where it inhibits hepatic HMG-CoA reductase and modulates gluconeogenesis; acetate serves as a substrate for peripheral tissues.

Insoluble Non-Viscous Fiber

Insoluble fibers do not dissolve in aqueous solutions and resist colonic bacterial fermentation:

Major Types: Cellulose (unbranched polymer of β ( 1 → 4 ) \beta(1\to4) β ( 1 → 4 ) -linked D-glucose), hemicelluloses (xylans, glucuronoxylans), and lignin (a complex non-carbohydrate polymer of phenylpropane units).

Physiological Mechanisms: Insoluble fibers add physical bulk to the stool by mechanically irritating the colonic mucosa, stimulating water and mucous secretion, and accelerating colonic transit time. This reduces intraluminal colonic pressure, protecting against constipation, diverticulosis, and hemorrhoids.

Note

The Philippine Dietary Reference Intakes (PDRI 2015) recommend 20 to 25 g/day of dietary fiber for adults of both sexes. Children's recommendations rise with age, from 6-7 g/day at 1-2 years to 21-23 g/day at 16-18 years.

Digestion, Brush Border Hydrolysis, and Monosaccharide Absorption

Carbohydrate digestion is an ordered, multi-compartment process converting dietary starch and disaccharides into absorbable monosaccharides. Dietary Starches (Amylose, Amylopectin)

  • │
  • ▼ [Salivary Amylase: mouth]
  • Short Dextrins, Maltose, Maltotriose
  • │
  • ▼ [Gastric Phase: acid inactivation of amylase at pH < 3.5]
  • Acid Chyme entering Duodenum
  • │
  • ▼ [Pancreatic Alpha-Amylase + Bicarbonate: duodenum]
  • Maltose, Maltotriose, Alpha-Limit Dextrins
  • │
  • ▼ [Brush Border Disaccharidases: jejunum]
  • Glucose, Galactose, Fructose
  • │
  • ├──────────────────────────────┬──────────────────────────────┐
  • ▼ [SGLT-1: Active Symport] ▼ [SGLT-1: Active Symport] ▼ [GLUT-5: Facilitated Diffusion]
  • Glucose Galactose Fructose
  • │ │ │
  • └──────────────────────────────┴──────────────────────────────┘
  • │
  • ▼ [Basolateral GLUT-2]
  • Portal Blood Flow
  • Luminal Digestion

Oral Cavity: Salivary α \alpha α -amylase (ptyalin) initiates digestion by cleaving internal α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) bonds of starch. It cannot cleave terminal bonds or α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch linkages. Its optimum pH is 6.8, and it is rapidly inactivated by gastric hydrochloric acid in the stomach.

Small Intestinal Lumen: Pancreatic α \alpha α -amylase, secreted into the duodenum in response to cholecystokinin (CCK) and secretin, hydrolyzes starches into maltose (disaccharide), maltotriose (trisaccharide), and α \alpha α -limit dextrins (branched oligosaccharides containing the original α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch points).

Brush Border Disaccharidases

The microvillar membrane of enterocytes expresses specific anchored glycoprotein disaccharidases:

Maltase-Glucoamylase: Cleaves terminal α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) bonds of maltose, maltotriose, and linear oligosaccharides, releasing free glucose.

Sucrase-Isomaltase Complex: A bifunctional enzyme. The isomaltase subunit is the only intestinal enzyme capable of cleaving the α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) bonds of α \alpha α -limit dextrins; the sucrase subunit cleaves sucrose into D-glucose and D-fructose.

Lactase (Lactase-Phlorizin Hydrolase): Hydrolyzes the β ( 1 → 4 ) \beta(1\to4) β ( 1 → 4 ) linkage of lactose into D-glucose and D-galactose. In primary lactase deficiency (adult-type hypolactasia), unabsorbed lactose exerts an osmotic draw in the ileum and colon, causing watery diarrhea, while colonic bacterial fermentation produces lactic acid, hydrogen gas ( H 2 H_2 H 2 ​ ), carbon dioxide ( C O 2 CO_2 C O 2 ​ ), and methane ( C H 4 CH_4 C H 4 ​ ), resulting in abdominal distention, cramping, and flatulence.

Monosaccharide Transporters

Monosaccharides enter and exit enterocytes through specific carrier proteins:

SGLT-1 (Sodium-Glucose Cotransporter 1): Located on the apical (luminal) brush border membrane. It transports glucose and galactose into the enterocyte against their steep intracellular concentration gradients via secondary active symport , moving two N a + Na^+ N a + ions down their electrochemical gradient for every monosaccharide transported. The required intracellular sodium gradient is actively maintained by the ATP-consuming basolateral N a + / K + Na^+/K^+ N a + / K + ATPase pump.

GLUT-5: Located on the apical membrane, GLUT-5 is a uniporter mediating the facilitated diffusion of fructose . Because it is non-energy-dependent, fructose absorption is concentration-dependent and has a limited saturable capacity, explaining why large oral boluses of free fructose trigger osmotic diarrhea and abdominal distress.

GLUT-2: Positioned primarily on the basolateral membrane , GLUT-2 exports glucose, galactose, and fructose out of the enterocyte into the interstitial space and portal capillaries via facilitated diffusion. Under high luminal glucose concentrations, GLUT-2 can also transiently translocate to the apical membrane to facilitate rapid bulk glucose clearance.

Transporter Cellular Location Primary Substrates Transport Mechanism Tissue Distribution & Function

SGLT-1 Apical enterocyte membrane Glucose, Galactose Secondary active ( 2 N a + : 1 2Na^+ : 1 2 N a + : 1 sugar) Intestinal absorption; renal tubular reabsorption (S3 segment)

GLUT-1 Plasma membrane Glucose, Galactose Facilitated diffusion (low K m ≈ 1 mM K_m \approx 1\text{ mM} K m ​ ≈ 1 mM ) Erythrocytes, blood-brain barrier, endothelial cells; basal glucose supply

GLUT-2 Basolateral enterocyte, hepatocytes, β \beta β -cells Glucose, Galactose, Fructose Facilitated diffusion (high K m ≈ 15 – 20 mM K_m \approx 15–20\text{ mM} K m ​ ≈ 15–20 mM ) Bidirectional flux in liver; pancreatic glucose sensing; basolateral enterocyte export

GLUT-3 Neuronal membrane Glucose Facilitated diffusion (low K m ≈ 1.5 mM K_m \approx 1.5\text{ mM} K m ​ ≈ 1.5 mM ) Neurons and brain tissue; high-affinity glucose uptake during hypoglycemia

GLUT-4 Intracellular vesicles → \to → plasma membrane Glucose Facilitated diffusion ( K m ≈ 5 mM K_m \approx 5\text{ mM} K m ​ ≈ 5 mM ) Insulin-dependent ; skeletal muscle, cardiac muscle, adipose tissue

GLUT-5 Apical enterocyte membrane, spermatozoa Fructose Facilitated diffusion Specific fructose absorption in jejunum; non-glucose transporting

Important

GLUT-4 is the only insulin-regulated glucose transporter. In the basal state, ~90% of GLUT-4 resides sequestered in intracellular tubulovesicular structures. Insulin binding to its tyrosine kinase receptor triggers IRS-1 phosphorylation, PI3K activation, and Akt/PKB signaling, causing GLUT-4 vesicles to fuse with the sarcolemma or adipocyte plasma membrane. Physical exercise independently stimulates GLUT-4 translocation via AMP-activated protein kinase (AMPK), allowing muscle contraction to lower blood glucose even in insulin-resistant states.

  • Central Carbohydrate Metabolic Pathways Extracellular Glucose
  • │
  • ▼ (GLUT-1, 2, 3, 4)
  • Intracellular Glucose
  • │
  • Hexokinase/Glucokinase ────┼────► (Consumes 1 ATP)
  • ▼
  • Glucose-6-Phosphate (G6P)
  • │
  • ┌────────────────────────┼────────────────────────┐
  • ▼ ▼ ▼
  • [Glycogenesis] [Glycolysis] [Pentose Phosphate Pathway]
  • Glucose-1-Phosphate Fructose-6-Phosphate 6-Phosphogluconate
  • │ │ │
  • UDP-Glucose ▼ (PFK-1: ATP/AMP) ▼ (G6PD: generates NADPH)
  • │ Fructose-1,6-BP Ribose-5-Phosphate
  • ▼ │
  • Glycogen ▼
  • Pyruvate (Yield: 2 ATP, 2 NADH)
  • │
  • ┌─────────┴─────────┐
  • ▼ ▼
  • (Anaerobic) (Aerobic / Mitochondria)
  • Lactate Acetyl-CoA
  • │
  • ▼
  • Citric Acid Cycle (TCA)
  • │
  • ▼ (NADH, FADH2)
  • Electron Transport Chain
  • │
  • ▼
  • 30–32 ATP / Glucose
  • 1. Glycolysis (Embden-Meyerhof Pathway)

Glycolysis is a ten-step cytosolic pathway that converts one molecule of glucose ( C 6 C_6 C 6 ​ ) into two molecules of pyruvate ( C 3 C_3 C 3 ​ ), producing a net yield of 2 ATP (substrate-level phosphorylation) and 2 NADH .

Three irreversible, allosterically regulated enzymatic steps govern glycolytic flux:

Step 1: Hexokinase vs. Glucokinase (Glucose → \to → Glucose-6-Phosphate):

Hexokinase (Isozymes I–III): Expressed in extrahepatic tissues. Exhibits a low K m K_m K m ​ (high affinity, ≈ 0.05 – 0.1 mM \approx 0.05–0.1\text{ mM} ≈ 0.05–0.1 mM ) and a low V m a x V_{max} V ma x ​ , operating at maximum velocity even during fasting. It is allosterically inhibited by its product, glucose-6-phosphate (G6P).

Glucokinase (Hexokinase IV): Localized exclusively to hepatocytes and pancreatic β \beta β -cells. Exhibits a high K m K_m K m ​ (low affinity, ≈ 10 mM \approx 10\text{ mM} ≈ 10 mM ) and a high V m a x V_{max} V ma x ​ . It is not inhibited by G6P, allowing the liver to rapidly clear high postprandial glucose loads from the portal vein. In the fasting state, glucokinase is bound and sequestered in the nucleus by glucokinase regulatory protein (GKRP); high cytosolic glucose promotes its nuclear release.

Step 3: Phosphofructokinase-1 (PFK-1): The rate-limiting, committed step of glycolysis, converting fructose-6-phosphate to fructose-1,6-bisphosphate while consuming one ATP.

Allosteric Activators: Fructose-2,6-bisphosphate (F-2,6-BP) is the most potent physiological activator, overriding high-energy inhibition. AMP and ADP also activate PFK-1.

Allosteric Inhibitors: ATP and citrate (signaling abundant energy and TCA cycle intermediate availability).

Hormonal Control of F-2,6-BP: Regulated by the bifunctional tandem enzyme PFK-2 / FBPase-2 . Insulin stimulates protein phosphatase-1, dephosphorylating the enzyme, activating PFK-2, elevating F-2,6-BP, and driving glycolysis. Glucagon activates cAMP-dependent Protein Kinase A (PKA), phosphorylating the enzyme, which inactivates PFK-2 and activates FBPase-2, depleting F-2,6-BP and halting glycolysis.

Step 10: Pyruvate Kinase: Catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate, generating ATP.

Activators: Fructose-1,6-bisphosphate ( feedforward activation ).

Inhibitors: ATP, acetyl-CoA, and alanine.

Hormonal Regulation: Glucagon triggers PKA phosphorylation of hepatic pyruvate kinase, inactivating it to prevent PEP consumption during gluconeogenesis.

2. Aerobic vs. Anaerobic Fates of Pyruvate and the Cori Cycle

Aerobic Oxidation: In the presence of oxygen, pyruvate enters the mitochondrial matrix via the mitochondrial pyruvate carrier (MPC) and is oxidatively decarboxylated to Acetyl-CoA by the multienzyme Pyruvate Dehydrogenase (PDH) Complex , generating 1 NADH and 1 C O 2 CO_2 C O 2 ​ . The PDH complex requires five coenzymes: thiamine pyrophosphate (TPP from B 1 B_1 B 1 ​ ), flavin adenine dinucleotide (FAD from B 2 B_2 B 2 ​ ), nicotinamide adenine dinucleotide ( N A D + NAD^+ N A D + from B 3 B_3 B 3 ​ ), coenzyme A (CoA from B 5 B_5 B 5 ​ ), and lipoic acid.

Anaerobic Glycolysis: In tissues lacking mitochondria (mature erythrocytes) or poorly oxygenated tissues (intensely contracting skeletal muscle), pyruvate is reduced to L-lactate by cytosolic lactate dehydrogenase (LDH) . This reaction is vital because it oxidizes NADH back to N A D + NAD^+ N A D + , replenishing the cellular N A D + NAD^+ N A D + required for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to maintain glycolytic ATP synthesis.

The Cori Cycle: Lactate produced by anaerobic tissues enters the circulation, travels to the liver, and is re-oxidized to pyruvate by hepatic LDH. Hepatic gluconeogenesis converts pyruvate back into glucose at the expense of 6 ATP equivalents, which is then released back into the blood.

3. Citric Acid Cycle (Krebs / TCA Cycle)

Operating within the mitochondrial matrix, the citric acid cycle completely oxidizes the two-carbon acetyl unit of acetyl-CoA to two molecules of C O 2 CO_2 C O 2 ​ . In each turn of the cycle, condensation of acetyl-CoA with oxaloacetate generates citrate (via citrate synthase). Subsequent oxidations yield:

  • 3 NADH (via isocitrate dehydrogenase, α \alpha α -ketoglutarate dehydrogenase, and malate dehydrogenase)
  • 1 F A D H 2 FADH_2 F A D H 2 ​ (via succinate dehydrogenase / Complex II)
  • 1 GTP or ATP (via succinyl-CoA synthetase)

Oxidation of these reducing equivalents through the mitochondrial electron transport chain (oxidative phosphorylation) yields ≈ 10 ATP \approx 10\text{ ATP} ≈ 10 ATP per acetyl-CoA, or 30 – 32 ATP 30–32\text{ ATP} 30–32 ATP per mole of fully oxidized glucose.

4. Gluconeogenesis

Gluconeogenesis is the synthesis of glucose from non-carbohydrate precursors (lactate, glycerol, and glucogenic amino acids, primarily alanine and glutamine). It occurs primarily in the liver (~90%) and to a lesser extent in the renal cortex (~10%; increasing up to 40% during prolonged starvation or chronic metabolic acidosis). Gluconeogenesis bypasses the three irreversible steps of glycolysis:

Pyruvate to Phosphoenolpyruvate (PEP): Requires two steps. Mitochondrial Pyruvate Carboxylase carboxylates pyruvate to oxaloacetate (consuming 1 ATP, requires biotin , allosterically activated by acetyl-CoA ). Oxaloacetate is reduced to malate or transaminated to aspartate to exit the mitochondria, then reconverted to oxaloacetate in the cytosol. Cytosolic/mitochondrial PEP Carboxykinase (PEPCK) then converts oxaloacetate to PEP (consuming 1 GTP, induced by glucagon, cortisol, and epinephrine).

Fructose-1,6-Bisphosphate to Fructose-6-Phosphate: Catalyzed by Fructose-1,6-Bisphosphatase-1 (FBPase-1) . This is the rate-limiting enzyme of gluconeogenesis. It is allosterically inhibited by AMP and F-2,6-BP, and stimulated by ATP and citrate.

Glucose-6-Phosphate to Free Glucose: Catalyzed by Glucose-6-Phosphatase , located in the lumen of the endoplasmic reticulum. It is expressed in the liver and kidneys, but absent in skeletal muscle . Consequently, skeletal muscle glycogen cannot directly supply free glucose to the systemic circulation to correct hypoglycemia; muscle glycogen can only be used intracellularly for muscle contraction.

5. Glycogenesis and Glycogenolysis

Glycogenesis: G6P is converted to G-1-P by phosphoglucomutase, then activated to UDP-glucose by UDP-glucose pyrophosphorylase. Glycogen Synthase (the rate-limiting enzyme) transfers glucosyl residues from UDP-glucose to glycogen chains via α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) linkages. A glycogen branching enzyme (amylo- α ( 1 → 4 ) → α ( 1 → 6 ) \alpha(1\to4)\to\alpha(1\to6) α ( 1 → 4 ) → α ( 1 → 6 ) -transglucosidase) creates α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch points every 8–12 units. Glycogen synthase is activated by insulin (via protein phosphatase-1 dephosphorylation) and high G6P; it is inactivated by glucagon and epinephrine (via PKA phosphorylation).

Glycogenolysis: Glycogen Phosphorylase (the rate-limiting enzyme, requiring pyridoxal phosphate [PLP / Vitamin B 6 B_6 B 6 ​ ] ) cleaves α ( 1 → 4 ) \alpha(1\to4) α ( 1 → 4 ) bonds phosphorolytically, releasing glucose-1-phosphate until four glucosyl residues remain before an α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) branch point (forming a "limit dextrin"). A bifunctional debranching enzyme (4- α \alpha α -D-glucanotransferase + amylo- α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) -glucosidase) transfers three outer glucosyl residues to a nearby chain and hydrolyzes the remaining α ( 1 → 6 ) \alpha(1\to6) α ( 1 → 6 ) -linked glucose as free glucose (~10% of glycogen residues). Hepatic glycogen phosphorylase is activated by glucagon and epinephrine via PKA; muscle phosphorylase is allosterically activated by AMP and C a 2 + Ca^{2+} C a 2 + -calmodulin.

6. Pentose Phosphate Pathway (Hexose Monophosphate Shunt)

This cytosolic pathway operates in tissues requiring high levels of reductive biosynthesis (adrenal cortex, liver, lactating mammary glands, adipose tissue) and erythrocytes:

Oxidative Branch (Irreversible): Glucose-6-phosphate is oxidized by Glucose-6-Phosphate Dehydrogenase (G6PD) , generating 2 NADPH per G6P and ribulose-5-phosphate. G6PD is rate-limiting and strictly regulated by the N A D P + / N A D P H NADP^+/NADPH N A D P + / N A D P H ratio.

Functions of NADPH:

Drives reductive biosynthetic pathways: fatty acid synthesis, cholesterol synthesis, and steroid hormone production.

Maintains cellular antioxidant defenses: reduces oxidized glutathione ( G S S G GSSG GSSG ) back to reduced glutathione ( G S H GSH GS H ) via glutathione reductase , enabling glutathione peroxidase to neutralize reactive oxygen species ( H 2 O 2 H_2O_2 H 2 ​ O 2 ​ ).

Serves as a cofactor for cytochrome P450 monooxygenases and phagocytic NADPH oxidase in neutrophils.

Non-Oxidative Branch (Reversible): Interconverts pentose phosphates with glycolytic intermediates (fructose-6-phosphate and glyceraldehyde-3-phosphate) via transketolase (requires thiamine pyrophosphate [TPP] ) and transaldolase, supplying ribose-5-phosphate for DNA/RNA nucleotide synthesis.

G6PD Deficiency (Favism): An X-linked recessive disorder and the most common human enzyme defect worldwide. Erythrocytes lack mitochondria and depend exclusively on G6PD for NADPH. When exposed to oxidative triggers (infections, fava beans, primaquine, sulfonamides), depleted GSH causes hydrogen peroxide to oxidize hemoglobin into insoluble Heinz bodies , leading to acute intravascular and extravascular hemolytic anemia.

Glycemic Index (GI) and Glycemic Load (GL)

In medical nutrition therapy, carbohydrates are evaluated not merely by their chemical mass, but by their physiological impact on postprandial glycemia and insulinemia.

Glycemic Index (GI)

The Glycemic Index measures the relative rise in blood glucose concentration following consumption of a defined quantity of available carbohydrate compared to an identical quantity of a reference carbohydrate (pure D-glucose or white bread, standard index = 100):

GI = ( iAUC test food iAUC reference food ) × 100 \text{GI} = \left( \frac{\text{iAUC}_{\text{test food}}}{\text{iAUC}_{\text{reference food}}} \right) \times 100 GI = ( iAUC reference food ​ iAUC test food ​ ​ ) × 100

Where iAUC \text{iAUC} iAUC represents the incremental area under the 2-hour blood glucose response curve after ingesting 50 grams of available (glycemic) carbohydrate from the test food.

  • Low GI: ≤ 55 \le 55 ≤ 55 (e.g., legumes, intact whole oats, barley, apples, lentils)
  • Medium GI: 56 – 69 56–69 56–69 (e.g., brown rice, sweet potato, whole wheat bread)
  • High GI: ≥ 70 \ge 70 ≥ 70 (e.g., white jasmine rice, white baguette, cornflakes, boiled potatoes, glucose)
  • Determinants of Glycemic Index

Starch Architecture: High amylose starches have a lower GI than high amylopectin starches due to tight helical packing.

Particle Size and Physical Entrapment: Intact whole grains retain an outer fibrous bran layer that slows amylolytic enzyme access compared to finely milled flours.

Starch Gelatinization and Retrogradation: Cooking hydrates and swells starch granules (gelatinization), increasing enzyme accessibility and elevating GI. Cooling cooked starches (such as chilled cooked rice or potatoes) causes amylose polymers to recrystallize into insoluble retrograded resistant starch (Type 3 RS) , lowering the GI.

Co-ingestion of Fat, Protein, and Acid: Dietary fats and proteins trigger CCK and enterogastrone release, delaying gastric emptying and flattening postprandial glucose curves. Organic acids (acetic acid in vinegar, lactic acid in fermented sourdough) lower gastric pH and suppress gastric motility.

Glycemic Load (GL)

While GI reflects carbohydrate quality , it fails to account for the typical portion size or carbohydrate density of a standard serving. The Glycemic Load combines both quality and quantity:

GL = GI × Available Carbohydrate per serving (g) 100 \text{GL} = \frac{\text{GI} \times \text{Available Carbohydrate per serving (g)}}{100} GL = 100 GI × Available Carbohydrate per serving (g) ​

  • Low GL: ≤ 10 \le 10 ≤ 10
  • Medium GL: 11 – 19 11–19 11–19
  • High GL: ≥ 20 \ge 20 ≥ 20
  • Clinical Example & Comparison

Consider fresh watermelon versus boiled white rice:

Watermelon: A high GI of 72 . However, watermelon is 92% water; a standard 120 g slice contains only 6 g of available carbohydrate: GL = 72 × 6 100 = 4.32 ( Low GL ) \text{GL} = \frac{72 \times 6}{100} = 4.32 \quad (\text{Low GL}) GL = 100 72 × 6 ​ = 4.32 ( Low GL )

Boiled White Rice: A high GI of 73 . A standard cooked serving (1 cup, ~160 g) provides 45 g of available carbohydrate: GL = 73 × 45 100 = 32.85 ( High GL ) \text{GL} = \frac{73 \times 45}{100} = 32.85 \quad (\text{High GL}) GL = 100 73 × 45 ​ = 32.85 ( High GL )

Watermelon produces a brief, modest postprandial glucose excursion despite its high GI because of its minimal carbohydrate density, whereas white rice delivers a massive total glycemic impact. Prescribing low-GL diets improves glycated hemoglobin (HbA1c), reduces postprandial glycemic excursions, and improves lipid profiles in individuals with diabetes mellitus.